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Abstract Transplantation of neural-like cells is consid-
ered as a promising therapeutic strategy developed for
neurodegenerative disease in particular for ischemic stroke.
Since cell survival is a major concern following cell
implantation, a number of studies have underlined the
protective effects of preconditioning with hypoxia or
hypoxia mimetic pharmacological agents such as deferox-
amine (DFO), induced by activation of hypoxia inducible
factor-1 (HIF-1) and its target genes. The present study has
investigated the effects of DFO preconditioning on some
factors involved in cell survival, angiogenesis, and neuro-
genesis of neural-like cells derived from human Wharton’s
jelly mesenchymal stem cells (HWJ-MSCs) in presence of
hydrogen peroxide (H2O2). HWJ-MSCs were differentiated
toward neural-like cells for 14 days and neural cell markers
were identified using immunocytochemistry. HWJ-MSC-
derived neural-like cells were then treated with 100 lM
DFO, as a known hypoxia mimetic agent for 48 h. mRNA
and protein expression of HIF-1 target genes including
brain-derived neurotrophic factors (BDNF) and vascular
endothelial growth factor (VEGF) significantly increased
using RT-PCR and Western blotting which were reversed
by HIF-1a inhibitor, while, gene expression of Akt-1, Bcl-
2, and Bax did not change significantly but pAkt-1 was up-
regulated as compared to poor DFO group. However,
addition of H2O2 to DFO-treated cells resulted in higher
resistance to H2O2-induced cell death. Western blotting
analysis also showed significant up-regulation of HIF-1a,
BDNF, VEGF, and pAkt-1, and decrease of Bax/Bcl-2
ratio as compared to poor DFO. These results may suggest
that DFO preconditioning of HWJ-MSC-derived neural-
like cells improves their tolerance and therapeutic potential
and might be considered as a valuable strategy to improve
cell therapy.
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Introduction
Endogenous neurogenesis is known as a process of new
cells generation from neural stem cells, in order to replace
some damaged neural cells in neurodegenerative disorders.
However, it seems that endogenous cells generation is
limited and may even decrease in some conditions such as
chronic stress, Alzheimer’s disease, depression, and aging.
Hence, in regenerative medicine, transplantation of
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exogenous stem cells has been considered as the most
reliable approach for repairing CNS neural damages for
many acute or chronic neurodegenerative disorders (Abdel-
Salam 2011; Bliss et al. 2007).
An efficient cell therapy approach depends on sustain
viability of the cells after transplantation, in order to sur-
vive and reach to the injured tissue target, and to resist
against cytotoxic factors encountered (Tavakol et al. 2015).
Earlier studies indicated that the transplanted cells in CNS
are at high risk of apoptosis so that a large number of cells
die after transplantation causing extra burdens to the host
damaged tissue as well as reduced therapeutic efficiency of
cell therapy (Modo et al. 2003; Sortwell et al. 2000;
Tavakol et al. 2014; Zawada et al. 1998). Thus, strategies
that promote survival of transplanted cells and support
regenerative mechanisms may improve and enhance the
therapeutic potential of stem cell therapy.
Among the others, some studies have shown that cell
survival enhanced in sublethal hypoxia, with increasing
secretion of some growth factors such as vascular
endothelial growth factor (VEGF), erythropoietin (EPO),
brain-derived neurotrophic factors (BDNF), insulin-like
growth factor-2 (IGF-2), and others (Li et al. 2008; Madri
2009). Both BDNF and VEGF are known to be neuro-
protective and angiogenic agents and play a critical role in
neural survival (Chen et al. 2013a; Sun et al. 2003). In
particular, they perform their effects due to stimulation of
phosphatidyl inositol 3-kinase (PI3K)/Akt signaling path-
way that lead to higher phosphorylation of Akt-1 and up-
regulation of anti-apoptotic proteins such as Bcl2. Besides,
Akt activates NF-jB and regulates signaling pathway that
is resulted in transcription of pro-survival genes (Gerber
et al. 1998a, 1998b; Almeida et al. 2005). Bcl-2, is con-
sidered as an important anti-apoptotic protein and localized
in the mitochondrial membrane, nuclear envelope, and
reticulum endoplasmic and stabilizes membrane perme-
ability, preserves mitochondrial integrity, and suppresses
the release of cytochrome c (Kannan and Jain 2000;
Scorrano and Korsmeyer 2013). BAX, the other member of
Bcl2 family, promotes apoptosis by binding to and antag-
onizing the Bcl-2 protein (Eslami et al. 2014; Lalier et al.
2007; Sharifi et al. 2010). The balance between the pro-
and anti-apoptotic proteins of the Bcl-2 family is important
in apoptosis progression. Therefore, the Bax/Bcl-2 ratio is
an important predictor of apoptosis (Oltvai et al. 1993).
Hypoxia inducible factor-1 (HIF-1), as the key regulator
of cellular response to the changes in oxygen concentra-
tion, is a heterodimeric structure composed of two subunits
including a-subunit (HIF-1a) and b-subunit (HIF-1b). a-
subunit (HIF-1a) is an unstable protein that is degraded
under typical oxygen conditions due to hydroxylation by
members of the prolyl-4 hydroxylase domain family (PHD)
and later is ubiquitinated and tags for proteasomal
degradation. Molecular oxygen and iron (II) are required
for PHD activity as co-substrate, so PHD activity is
increased in normoxia that finally leads to HIF-1a
destruction. But in hypoxic conditions and also in the
presence of iron chelators, HIF-1a is not degraded. It is
accumulated and translocated into the nucleus. Then it via
dimerization with the HIF-1b subunit forms active tran-
scription factor (Gorres and Raines 2010; Najafi and Sharifi
2013).
Compelling evidences indicate that under hypoxic con-
ditions, HIF-1 transcriptional factor, will be activated and
bound to promoter of about 100 genes and will affect the
expression of numerous genes and proteins including those
are involved in cell survival and apoptosis, angiogenesis,
and neurogenesis such as VEGF and BDNF(Hirota and
Semenza 2006; Madri 2009; Mazumdar et al. 2010; Piret
et al. 2002).
Activation of the HIF-1 system by iron chelators, as well
as hypoxia has led to the proposal that deferoxamine
(DFO), as an emerging neuroprotective agent, can improve
regenerative capability of transplanted cells before trans-
plantation, through HIF-1 dependent mechanisms.
On the basis of these investigations, the present in vitro
study aimed to investigate the preconditioning effect of
DFO on tolerance and therapeutic potential of human
Wharton’s jelly mesenchymal stem cells-derived neural-
like cells in the presence of hydrogen peroxide in order to
enhance the efficacy of cell therapy in regenerative medi-
cine for neurodegenerative disorders.
Materials and Methods
HWJ-MSC Isolation, Characterization,
and Adipogenic and Osteogenic Differentiation
HWJ-MSC were isolated, propagated, characterized by
FACS flow cytometry, and differentiated to adipocytes and
osteocytes in our laboratory by the methods described
earlier (Salehinejad et al. 2012).
Neural Differentiation
For neural differentiation, according to the procedure
described before (Salehinejad et al. 2014), the HWJ-MSCs
at the fourth passage were seeded into 75-cm2 Costar
culture flasks in a humidified atmosphere of 95 % air/5 %
CO2 at a density of 1 9 10
4 cells/ml with basic medium
for 24 h. Then the cells were treated with 10-2 M RA
(retinol acetate; Sigma), 20 ng/ml EGF (epidermal growth
factor; sigma), and 20 ng/ml bFGF (basic fibroblast growth
factor; sigma) for 2 weeks.
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Cresyl Violet Staining
The Cresyl Violet method uses basic aniline dye to stain
RNA blue, and is used to highlight important structural
features of neurons, the Nissl substance. The cells were
fixed by 4 % paraformaldehyde (PFA) for 10 min and
dehydrated in decreasing concentration of ethanol: 100, 95,
and 70 %, 3 min for each step and then washed twice in
PBS for 10 min and incubated for 2 min in staining solu-
tion (0.25 % Cresyl Violet, 0.8 % glacial acetic acid,
0.6 mM sodium acetate). The incubated cells were then
washed four times in PBS and mounted for microscopic
observation. The proportion of positive cells for Nissl
bodies was estimated by counting ten non-overlapping
microscopic fields for each slide and compared with con-
trol group and the level of significance was assessed by v2
test.
Immunocytochemistry
Immunocytochemistry (ICC) ICC was performed to
investigate the protein expression of nestin, b-tubulin III,
GFAP, 70 kDa neurofilament, and CNPase in the incubated
cells on the 14-day post-induction. The cells were fixed
with 4 % PFA for 30 min at room temperature. After
permeabilization with 0.2 % Triton X-100 (Sigma) for
10 min, the cells were incubated in goat serum followed by
incubation in primary antibodies overnight at 4 C: nestin
(MAB5326; 1:200), b-tubulin III (16230; chemicon/Milli-
pore; 1:100), GFAP (MAB360; 1:400), 70 kDa neurofila-
ment (MAB1615), and CNPase (MAB326; 1:200).
Afterwards, the cells were washed with 1*X PBS, and
incubated with a peroxidase kit and DAB chromogenic
substrate solution according to the manufacturer’s
instructions (DAKO). The slides were counterstained with
hematoxylin (DAKO) and examined by an optical micro-
scope with 920 magnification. The proportion of positive
cells for neural markers was estimated by counting ten non-
overlapping microscopic fields for each slide and compared
with undifferentiated cells as control group, and the level
of significance was assessed by v2 test.
Preconditioning with DFO and Calculation of Cell
Viability and Neural-Like Cell Proportion
After 2 weeks of differentiation under RA, EGF, bFGF, the
neurogenic media changed to basal media were refreshed
daily. In order to find the most appropriate time for the
initiation of treating with DFO (deferoxamine; Sigma), the
cells were trypsinized every 4 days and the percentages of
viable cells were estimated with trypan blue exclusion dye
test. Briefly, 10 ll 0.4 % trypan blue solution (Sigma) was
added to 10 ll cell suspension. Then 10 ll of mixed
suspension was injected into a hemocytometer, and the
number of viable cells was determined under a phase-
contrast microscope.
To choose the best time and concentration for further
preconditioning and to induce a cyto-protective phenotype
of HWJ-MSCs-derived neural-like cells, the cells were
cultured for 16 days with basal medium and then were
pretreated with DFO for different hours (24, 48, and 72 h)
and concentrations (10, 100, 200, and 400 lM). Proportion
of viable cells was evaluated by trypan blue staining, while
proportion of the neural-like cells was estimated by cresyl
violet (Sigma) staining and nestin immunoreactivity. Data
are presented as percentage of positive cells compared to
control in all groups. The level of significance was assessed
by repeated measures analysis of variance. Statistical sig-
nificance was assigned at a P value B0.05.
Hydrogen Peroxide Treatments
To investigate the tolerance of DFO preconditioned cells
against hydrogen peroxide (H2O2), as a common model of
lethal insult in ischemic areas of cerebral stroke, after 48 h
preconditioning with 100 lM DFO, the cells were rinsed
three times with basal medium and incubated with basal
medium containing 500 lM H2O2 for 24 h. Total cell
viability was measured by trypan blue staining, while
neural-like cell percentage was measured by cresyl violet
staining and nestin immunoreactivity. Data are presented as
percentage of positive cells compared to control in all
groups. The level of significance was assessed by v2 test.
Statistical significance was assigned at a P value B0.05.
Semiquantitative RT-PCR (sqRT-PCR)
To investigate the relative fold change gene expressions in
the mRNA level of genes involved in cell survival
including BDNF, VEGF, Bcl-2, Bax, and AKT-1 in DFO
pretreated cells and unpretreated cells, semiquantitative
reverse transcriptase polymerase chain reaction (sqRT-
PCR) was performed. Then to investigate the molecular
mechanism of HIF-1a, the expression of BDNF, VEGF,
Bcl-2, Bax, AKT-1 after 4 h pretreatment with 20 lM HIF-
1a inhibitor (sc-205346) and then treatment with DFO for
48 h was performed, as well.
Total RNA was isolated from the cells treated with poor
and rich 100 lM DFO media for 48 h using TRIZOL
reagent (Invitrogen) according to manufacturer’s instruc-
tions and was spectrophotometrically quantified. First-
strand cDNA was synthesized with 1 lg RNA in the
presence of 2 lg oligo_dT primer (Fermentase) and 200U
MMLV (Fermentase) in a total volume of 20 lL. The
reaction mixture was incubated for 1 h at 42 C, followed
by incubation at 72 C for 10 min. Aliquots of 5 ll of
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cDNA were subjected to PCR utilizing specific primers
(Table 1). The PCR conditions for primer sets were as
following: hot start at 95 C for 10 min; 35 amplification
cycles, each consisting of 94 C for 30 s; 53 C for 1 min
and 72 C for 3 min, and final extension step at 72 C for
5 min. PCR for b-Actin was performed at 94, 49, and
72 C, respectively. b-Actin was used as the internal con-
trol. PCR products were separated on 1.5 % agarose gels
and visualized by Nancy staining.
Western Blot
To analysis the difference between the selected protein
levels involved in cell survival including HIF-1a, BDNF,
VEGF, Bcl-2, Bax, Akt-1, and pAkt-1in pretreated cells
with DFO as compared to untreated cells, Western blotting
was done. Cultures of cells were exposed to DFO (100 lM)
for 48 h. The untreated and treated cultured cells were
trypsinized, washed twice with ice-cold PBS, and lysed in
0.2 ml of RIPA buffer (10 mM Tris–HCl; pH 7.4, 150 mM
NaCl, 5 mM EDTA, 1 % Triton X-100, 0.1 % sodium
dodecyl sulfate and 0.5 % sodium deoxycholate) contain-
ing protease and phosphatase inhibitor cocktails (Sigma)
and centrifuged at 15,0009g for 20 min at 4 C. The
protein concentration was determined using the Bradford
method (Bradford 1976). For immunoblotting, equal
amounts of proteins from each sample were loaded and
separated by SDS-PAGE (Laemmli 1970) and transferred
on a polyvinylidene difluoride (PVDF) membrane (Invit-
rogen). The blots were then blocked with 2 % skim milk
for 1 h at room temperature. After blocking, blots were
incubated with primary antibodies: Bax (ab7977; 1:1000),
Bcl-2 (ab7973; 1:100), pan AKT (ab8805; 1:500), phospho
AKT-1 (ab66138; 1:5000), BDNF (ab6201; 1:200), VEGF
(ab99511; 1:500), and HIF-1a (ab82832; 1:1000) overnight
at 4 C. The membrane was washed two times with 0.1 %
Tween 20 and TBST, and two times with 2 % skim milk,
10 min each. It was then incubated with horseradish per-
oxidase-conjugated anti-rabbit antibody (cell signaling) or
with horseradish peroxidase-conjugated anti-mouse anti-
body (cell signaling) for 1 h at room temperature. Finally,
protein bands were detected using enhanced chemilumi-
nescence (ECL) reagent (Pierce ECL Western blotting
substrate, Amersham Biosciences). As a control for protein
loading, the membranes were probed with a rabbit anti-b-
Actin antibody (Cell signaling). Protein bands were ana-
lyzed using Total lab software (Wales, UK). Also the
expression of these proteins was determined by Western
blotting after 4 h pretreatment with 20 lM HIF-1a inhi-
bitor and then treatment with DFO for 48 h.
In order to study the effect of DFO on selected protein
levels in cell culture exposed to H2O2, Western blot anal-
ysis was performed, as well. For this purpose, after 48 h
pretreatment with 100 lM DFO, the cells were rinsed three
times with basal media, and incubated with media con-
taining 500 lM H2O2 for 24 h, and then Western blot was
performed.
Results
HWJ-MSC Isolation, Cell Surface Characterization,
and Adipogenic and Osteogenic Differentiation
Cell morphology was tracked post-incubation using
inverted light microscopy. Ten days after explantation, the
migrating cells were detectable at the boundary the frag-
ments, being heterogenous in appearance. After three
passages, HWJ-MSCs gained relatively homogeneous in
morphology with elongated, fibroblast, or spindle-like
shape.
To investigate HWJ-MSCs multipotency, the cells were
treated by adipogenic and osteogenic media. After
3 weeks, the cells were stained with Oil red O and lipid
droplets were appeared as cherry red spheres within indi-
vidual cells. Similarly, the extracellular matrix deposited
with calcium phosphate precipitates. MSCs became Ali-
zarin Red positive at the end of the third week. Non-treated
cells as a control group did not show adipocyte or osteo-
blast transformation even after 3 weeks of cultivation.
Figures are provided as supplementary data.
The immunophenotype investigation was based on the
flow cytometric analysis of MSC markers (CD44,CD105,
CD90, and CD73) and hematopoietic markers (CD34 and
CD45). The analysis showed that mesenchymal stem cell
markers including CD44,CD105, CD90, and CD73 were
Table 1 Primers used for
semiquantitative RT-PCR
Gene Primer sequence (50–30)
BDNF F:GTCTTTTTGTCTGCTGCCGT R:AACATGTCCATGAGGGTCCG
VEGF F:TCTCTACCCCAGGTCAGACG R:AGCAATGTCCTGAAGCTCCC
Akt-1 F:ATTGTTCTGAGGGCTGAGGC R:TGGACGATAGCTTGGAGGGA
Bcl-2 F:TTAGCCCCCGTGACCTCTTA-30 R:TGTGCTGCTATCCTGCCAAA
Bax F:GCCTCACTCACCATCTGGAA R:TTACCCCCTCAAGACCACTCT
b-Actin F:CACCATGGATGATGATATCGC R:AGTCCATCACGATGCCAGTG
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expressed, while the hematopoietic cell surface markers
CD34 and CD45 did not express (Fig. 1).
Neural Differentiation Analysis by Cresyl Violet
Staining and Immunocytochemistry
To investigate the morphology of neural-like cells derived
from HWJ-MSCs, images were captured by phase-contrast
microscopy. After 14 days, changes in the shape of most
cells were observed. Some short neurite-like extensions
appeared after 7 days, and became easily recognizable
after 14 days. The cell bodies became increasingly pyra-
midal or spherical shape, exhibiting a typical neural
appearance. The development of neurite-like outgrowth
was remarkable.
The Nissl bodies were observed using cresyl violet
staining, as well. The results showed that there was an
increase in the percentage of the Nissl bodies that are
appeared as dark blue substances due to the staining of
ribosomal RNA, giving the cytoplasm a mottled appear-
ance in the induced cells compared with the control.
To identify neuro-glial differentiation after 14 days,
neural-like cells were studied by immunocytochemistry.
Neural-like cells were characterized by the expression of
cytoskeletal proteins including nestin, b-tubulin III, NF,
CNPase, and GFAP, which are expressed in mature neural
and glial cells. The cells treated with RA, EGF, and bFGF
exhibited significant higher percentage of positive cells for
neural markers as compared to non-differentiated controls
(Fig. 2).
Concentration Response and Time Course of DFO
Treatment on Viability of Neural-Like Cells
In order to find the best time for the initial treating with
DFO and the optimum concentration, the cells were tryp-
sinized every 4 days and the percentage of viable cells was
estimated with trypan blue exclusion dye test. The trypan
blue staining showed that on day 16,cell viability did not
significantly changed as compared to subsequent days
(Data not shown). The trypan blue exclusion test showed
that DFO could decrease total cell viability as compared to
control group at a concentration- and time-dependent
manner. But no significant cytotoxicity was shown at 100
lM incubation for 24 h and 48 h. Also cell preconditioning
with 10 lM DFO for 72 h did not cause significant cell
death measured by trypan blue staining. However, cresyl
violet staining and nestin immunoreactivity after DFO
treatment with these times and concentrations showed no
significant changes in neural-like cell percentage as com-
pared to control group (Fig. 3).
The Effect of DFO Treatment Increased
the Tolerance of Cells Against H2O2 Treatment
In order to evaluate tolerance of preconditioned cells with
DFO against H2O2, the cells were pretreated with DFO and
then challenged with H2O2. After 24 h H2O2 treatment,
cells treated in DFO poor medium showed lower viability
with trypan blue exclusion test, whereas the cells that
received preconditioning with DFO (100 lM for 48 h)
were more resistant to H2O2-induced cell death. Counting
the cells that were stained with cresyl violet or nestin
antibody confirmed an increased percentage of neural-like
cells with DFO preconditioning as compared with non-
preconditioned cells (Fig. 4).
Effect of DFO Treatment Increased Gene
Expression of BDNF and VEGF in sqRT-PCR
Analysis
sqRT-PCR was performed to investigate the relative fold
change gene expression of cells treated with DFO. Results
showed that BDNF and VEGF genes were overexpressed
after 48 h treatment with 100 lM DFO. The mRNA
expression of the Bcl-2 and Bax and Akt-1 genes did not
change significantly after treatment with 100 lM DFO for
Fig. 1 Flow cytometry analysis of HWJ-MSCs. The black histograms
are the antibody-stained HWJ-MSCs and the red histograms are the
isotype control cells. The proportion of stained cells was provided in the
histogram for each marker. HWJ-MSCs expressed mesenchymal
markers CD44, CD73, CD90, and CD105 and did not express
hematopoietic cell markers CD34 and CD45 (Color figure online)
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48 h. Moreover, the overexpression of BDNF and VEGF
genes by DFO decreased significantly in the HIF-1a inhi-
bitor (HIF-1a-I) pretreated cells—while Bcl-2, Bax, and
Akt-1 genes expression did not change significantly
(Fig. 5).
Effect of DFO Treatment Protein Expressions
of HIF-1a, BDNF, VEGF, and pAkt-1
Western blotting was performed to analyze the difference
between the selected protein levels under DFO and to study
the effect of DFO on selected protein levels after exposure
to H2O2. At the protein level, we observed HIF-1a, BDNF,
and VEGF up-regulation after DFO preconditioning.
Increased level of the phosphorylated Akt-1 at Ser 473 was
also observed by 48 h DFO pretreatment. Expression of
anti-apoptotic Bcl-2 protein and proapoptotic Bax protein
did not change significantly in the DFO-treated cells as
compared to non-treated ones. After 4 h pretreatment with
HIF-1a inhibitor and then treatment with DFO for 24 h, the
protein expression pattern displayed a shift toward the
control group, as evidenced by the down-regulation of HIF-
1a, VEGF, BDNF, and pAKT-1 levels (Fig. 6).
After exposure of DFO pretreated cells to H2O2, data
showed significant up-regulation of survival proteins
including HIF-1a, BDNF, VEGF, and pAkt-1 compared to
untreated cells with DFO and down-regulation of Bax/Bcl-
2 ratio as compared to unpretreated cells with DFO before
H2O2 insult (Fig. 7).
Discussion
The present study demonstrated that in vitro precondi-
tioning of the HWJ-MSC-derived neural-like cells with
DFO as a hypoxia mimetic agent could promote thera-
peutic potential of these cells and enhance cell tolerance in
challenge with hydrogen peroxide as a cytotoxic and an
Fig. 2 Neural differentiation, Cresyl Violet staining, and immuno-
cytochemistry staining on differentiated HWJ-MSCs to neural-like
cells. a Cytoplasm in spindle-like shape HWJ-MSCs before neural
differentiation, retracted toward the nucleus, and shaped to contracted
multipolar cell body with some process-like extensions. Arrows show
neural-like cells with branching processes. HWJ-MSCs differentiated
to neural-like cells with pyramidal or spherical forms and neurite-like
extensions on day 7 and b day 14 (920 magnification). c HWJ-MSCs
differentiated to neural-like cells after staining with cresyl violet.
Dark blue particles in the cytoplasm show Nissl bodies (920
magnification). In immunocytochemistry, cells with brown color
exhibit the neural markers d nestin, e b-tubulin III, f GFAP, g NF, and
h CNPase in differentiated HWJ-MSCs. Scale bars 50 lm (Color
figure online)
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etiological candidate for a number of neurodegenerative
disorders.
We could show that treating HWJ-MSC-derived neural-
like cells with 100 lM DFO for 48 h was safe and below
the toxic levels and did not significantly change the cell
viability and Bax/Bcl-2 ratio compared to the controls.
DFO preconditioning also led to stabilization of HIF-1a in
protein levels and overexpression of BDNF and VEGF in
mRNA and protein levels which was reversed by HIF-1a
inhibitor indicating that HIF-1a plays a critical role in
elevation of BDNF and VEGF expression. Earlier studies
have shown success in HIF-1a stabilization followed by
DFO treatment (Xiao et al. 2013). Also these results are in
consistent with earlier studies, indicating that DFO can
induce VEGF up-regulation in various cell types, such as
beta cells (Langlois et al. 2008), alveolar epithelial cells
(Pham et al. 2002), endothelial cells (Yamakawa et al.
2003), and bone marrow stromal cells (Potier et al. 2008).
Fig. 3 Total cell viability and
neural-like cell percentage after
preconditioning with DFO. The
cells were treated with different
concentrations of DFO for 24,
48, and 72 h. a Viability of total
cells was measured by trypan
blue exclusion test.
b Percentage of neural-like cells
was measured by cresyl violet
staining. c Percentage of the
neural-like cells was also
evaluated by nestin
immunoreactivity. Groups that
treated with 0 lM DFO were
regarded as control in all tests,
results were reported as the
mean ± SEM (n = 4), and
were significant at *P\ 0.05,
**P\ 0.01, and ***P\ 0.001
compared to control
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It has also been demonstrated that HIF-1a can induce
BDNF up-regulation in pulmonary artery endothelial cells
(Helan et al. 2014). Our observations are also consistent
with other studies suggesting that with hypoxic precondi-
tioning VEGF and BDNF levels increase in various cell
types including neural cells (Madri 2009; Majumdar et al.
2013; Wick et al. 2002). In contrast, these results were in
contrast to the study performed by Texel et al. reporting
that treatment of the human neuroblastoma SH-SY5Y cells
with DFO caused reduction of BDNF in mRNA and protein
levels (Texel et al. 2011). In another study, Zaman reported
that in cortical neuronal cultures exposed to increasing
concentrations of DFO, expression of BDNF mRNA was
unchanged (Zaman et al. 1999). Whether the cell source
and nature might have caused such differences need to be
explored in parallel experiments.
Moreover, this study indicated that preconditioning of
HWJ-MSC-derived neural-like cells with DFO could have
inhibited cell death induced by H2O2 as an important
Fig. 4 Total cell viability and neural-like cell percentage of precon-
ditioned cells with DFO after exposure to hydrogen peroxide. The
cells were treated with 100 lM DFO for 48 h, then exposed to
500 lM H2O2 for 24 h. a Cell viability after exposure to H2O2 was
measured by trypan blue exclusion test. b Percentage of neural-like
cells after exposure to H2O2was measured by Nissl body staining
using cresyl violet. c Percentage of the neural-like cells was also
evaluated by nestin immunoreactivity. Untreated cells are not treated
with DFO and not with H2O2. Results are reported as the mean ± -
SEM (n = 4) and are significant compared to untreated cells
(***P\ 0.001) and compared to treated cells only with H2O2
(###P\ 0.001)
Fig. 5 DFO preconditioning induced gene regulation. a Semiquanti-
tative analysis of genes expression of BDNF, VEGF, Bcl-2, Bax, and
Akt-1 was performed by densitometry. The expressions of genes are
normalized to optical b-Actin density. Data were represented as
mean ± SEM and were significant at ***P\ 0.001 versus untreated
cells while at ###P\ 0.001 versus treated cells with DFO and HIF-1a
inhibitor (n = 4). b BDNF and VEGF mRNA levels in the cells were
up-regulated after 48 h treatment with 100 lM DFO, revealed by RT-
PCR measurements. No significant change in the expression of the
proapoptotic gene, Bax and anti-apoptotic genes, Bcl-2 and Akt-1 was
observed under 100 lM DFO for 48 h. The gene expression pattern of
BDNF and VEGF displayed a shift to the control with pretreatment by
HIF-1a inhibitor for 4 h. b-Actin was used as a loading control
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cytotoxic factor as well as preventing H2O2-induced ele-
vation of Bax/Bcl2 ratio compared to untreated controls.
However, in agreement with current results, Zaman
et al.(1999) demonstrated that DFO prevents oxidative
stress-induced cell death in cortical neuronal cultures by
elevating the expression of HIF-1 and its target genes
(Zaman et al. 1999).
Fig. 6 DFO preconditioning induced protein regulation. a Quantita-
tive analysis of protein expression of HIF-1a, BDNF, VEGF, Bcl-2,
Bax, pAkt-1, and Akt-1 was performed by densitometry. The
expressions of proteins were normalized to optical b-Actin density.
Data showed that DFO markedly elevates HIF-1a, BDNF, VEGF, and
pAkt-1 protein levels, while were reversed by HIF-1a-I pretreatment.
Data were represented as mean ± SEM and were significant at
***P\ 0.001 versus untreated cells, while at #P\ 0.05 and
###P\ 0.001 versus treated cells with DFO and HIF-1a inhibitor
(n = 4). b Western blot analysis showed significant up-regulation of
HIF-1a, BDNF, VEGF, and pAkt-1 after 48 h treatment with 100 lM
DFO. The protein levels of HIF-1a, BDNF, VEGF, and pAkt-1
induced by the DFO treatment, down-regulated by pretreatment with
HIF-1a inhibitor (HIF-1a-I). The HIF-1 activation was inhibited by
the HIF-1a inhibitor. b-Actin was used as a loading control
Fig. 7 Protein levels of DFO preconditioned cells after the termina-
tion of H2O2 treatment. a Quantitative analysis of protein expression
of HIF-1a, BDNF, VEGF, Bcl-2, Bax, pAkt-1, and Akt-1 was
performed by densitometry after H2O2 treatment in the cells with
preconditioning with DFO. The expressions of proteins were
normalized to optical b-Actin density. b The protective proteins
Bcl-2 and pAkt-1 decreased and proapoptotic protein Bax increased
significantly after H2O2 treatment in the cells without preconditioning
with DFO. c The Bax/Bcl-2 ratio showed significant up-regulation in
group unpretreated with DFO before exposure to H2O2 compared to
treated groups with DFO. Data were represented as mean ± SEM and
were significant at **P\ 0.01 and ***P\ 0.001 versus untreated
cells and were significant at ##P\ 0.01 and ###P\ 0.001 versus
treated cells only with H2O2 (n = 4)
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These findings might reflect direct antioxidant properties
of DFO and/or indirect antioxidant effects of other factors
such as BDNF and EPO (erythropoietin) as a consequence
of DFO pretreatment (Amer et al. 2010; Tsai et al. 2012).
Also phosphorylated Akt-1, as a critical mediator of BDNF
and VEGF signaling pathway which induces neuronal sur-
vival, increased in DFO-treated cells compared to untreated
controls. These findings are in agreement with results
reported by Tejado et al.(2001) in which, under hypoxic
conditions and also after treatment with DFO, PC12 cells
were resistant to serum withdrawal-induced apoptosis. They
have demonstrated that these effects were due to activation
of the PI3 K/Akt pathway (Tejado et al. 2001).
Interestingly, it has previously been shown that neuro-
protective effects of DFO preconditioning may alterna-
tively be obtained by BDNF and VEGF (Brar et al. 2010;
Chen et al. 2013a, 2013b).
A number of in vivo studies have reported that reduction
in expression of HIF-1a leads to the increase in brain injury
after hypoxic ischemia, but others have claimed that
reduction or inhibition of HIF-1 level resulted in improved
brain injury after hypoxic-ischemic damage. Helton et al.
(2005) suggested that the neuroprotection found against
acute hypoxia in the HIF-1a deficient mice is mechanisti-
cally consistent with a predominant role of HIF-1a as a
proapoptotic marker and it is indicated that reduction in
expression of HIF-1a or inhibition of function are both
neuroprotective (Helton et al. 2005). In another study,
Chen et al. demonstrated that acute inhibition of HIF-1a is
neuroprotective due to the preservation of blood brain
barrier integrity and reducing brain edema (Chen et al.
2008a, 2008b). So, it seems that although the role of HIF-
1a has been extensively characterized in vitro, but more
investigations especially in vivo studies are needed to
evaluate the effect of enhanced HIF-1a level in damaged
brain.
This study would have been more complete if the
expression of BDNF and VEGF receptors—especially two
important receptors, TrkB and Flt-1 was measured after
DFO treatment. However, several studies have reported up-
regulation of these receptors under hypoxia (Li et al. 2005;
Martens et al. 2006, 2007). Also it would be valuable if the
expression of EPO is measured after DFO treatment. EPO
has been known as an anti-apoptotic and antioxidant agent
that is downstream of HIF-1 with neuroprotective effects
(Byts and Sire´n 2009; Wang and Semenza 1993).
Conclusion
In summary, our data showed for the first time that treating
WJ-MSC-derived neural-like cells with DFO increases
VEGF and BDNF expression, two important HIF-1
downstream genes, which are inhibited under HIF-1a
inhibition. Also DFO preconditioning enhances cell toler-
ance against H2O2-induced cell death. These results may
have clinical applications that preconditioning of MSC-
derived neural-like cells with DFO could advance tolerance
and the therapeutic potential of cells in order to enhance
efficiency of cell therapy in stroke or some other neu-
rodegenerative diseases after transplantation.
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